JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 50 filers reported holding JANUX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,021,326 | +6.5% | 6,351,322 | +25.5% | 0.01% | +20.0% |
| Q2 2023 | $60,095,389 | -51.7% | 5,062,796 | -50.8% | 0.01% | -16.7% |
| Q1 2023 | $124,403,584 | +68.5% | 10,281,288 | +83.4% | 0.01% | -14.3% |
| Q4 2022 | $73,829,176 | -12.7% | 5,605,860 | -10.3% | 0.01% | -22.2% |
| Q3 2022 | $84,589,000 | +18.9% | 6,247,392 | +7.2% | 0.01% | +28.6% |
| Q2 2022 | $71,132,000 | -12.6% | 5,825,704 | +2.6% | 0.01% | 0.0% |
| Q1 2022 | $81,407,000 | -17.3% | 5,676,926 | +13.7% | 0.01% | 0.0% |
| Q4 2021 | $98,480,000 | +25.9% | 4,991,402 | +38.1% | 0.01% | +16.7% |
| Q3 2021 | $78,202,000 | +70.0% | 3,615,431 | +96.1% | 0.01% | +50.0% |
| Q2 2021 | $45,997,000 | – | 1,843,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |